LAM-004

N/A

Report date: 2023/01/01 08:31:43
NME

Base Information

Drug NameLAM-004
Drug Alias NameLAM-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsSerine/threonine-protein kinase mTOR inhibitorsT lymphocytes inhibitors +[4] 
TargetsSerine/threonine-protein kinase mTORMethylmalonyl-CoA Mutase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrphAI Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrphAI Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A